Delayed drug hypersensitivity reactions – new concepts

Immune reactions to small molecular compounds such as drugs can cause a variety of diseases mainly involving skin, but also liver, kidney, lungs and other organs. In addition to the well‐known immediate, IgE‐mediated reactions to drugs, many drug‐induced hypersensitivity reactions appear delayed. Recent data have shown that in these delayed reactions drug‐specific CD4+ and CD8+ T cells recognize drugs through their T cell receptors (TCR) in an MHC‐dependent way. Immunohistochemical and functional studies of drug‐reactive T cells in patients with distinct forms of exanthems revealed that distinct T cell functions lead to different clinical phenotypes. Taken together, these data allow delayed hypersensitivity reactions (type IV) to be further subclassified into T cell reactions, which by releasing certain cytokines and chemokines preferentially activate and recruit monocytes (type IVa), eosinophils (type IVb), or neutrophils (type IVd). Moreover, cytotoxic functions by either CD4+ or CD8+ T cells (type IVc) seem to participate in all type IV reactions. Drugs are not only immunogenic because of their chemical reactivity, but also because they may bind in a labile way to available TCRs and possibly MHC‐molecules. This seems to be sufficient to stimulate certain, probably preactivated T cells. The drug seems to bind first to the fitting TCR, which already exerts some activation. For full activation, an additional interaction of the TCR with the MHC molecules is needed. The drug binding to the receptor structures is reminiscent of a pharmacological interaction between a drug and its (immune) receptor and was thus termed the p–i concept. In some patients with drug hypersensitivity, such a response occurs within hours even upon the first exposure to the drug. The T cell reaction to the drug might thus not be due to a classical, primary response, but is due to peptide‐specific T cells which happen to be stimulated by a drug. This new concept has major implications for understanding clinical and immunological features of drug hypersensitivity and a model to explain the frequent skin symptoms in drug hypersensitivity is proposed.

[1]  W. Pichler,et al.  T cell‐mediated hypersensitivity to quinolones: mechanisms and cross‐reactivity , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  I. Phillips,et al.  Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. , 2001, Biochemical pharmacology.

[3]  R. Victorino,et al.  Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury , 1997, Gut.

[4]  S. Roychowdhury,et al.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin , 2005, The AAPS Journal.

[5]  M. Britschgi,et al.  T-cell involvement in drug-induced acute generalized exanthematous pustulosis. , 2001, The Journal of clinical investigation.

[6]  C. Christiansen.  Late-onset allergy-like reactions to X-ray contrast media , 2002, Current opinion in allergy and clinical immunology.

[7]  I Kimber,et al.  Dendritic cells and cutaneous immune responses to chemical allergens. , 1992, Toxicology and applied pharmacology.

[8]  C. Brander,et al.  Characterization of lidocaine-specific T cells. , 1997, Journal of immunology.

[9]  M. Pirmohamed,et al.  Characterization of drug-specific T cells in lamotrigine hypersensitivity. , 2003, The Journal of allergy and clinical immunology.

[10]  Pichler,et al.  T‐cell‐mediated cytotoxicity against keratinocytes in sulfamethoxazol‐induced skin reaction , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[12]  W. Pichler,et al.  Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations , 2000, European Radiology.

[13]  M. Britschgi,et al.  Cellular and Molecular Pathophysiology of Cutaneous Drug Reactions , 2002, American journal of clinical dermatology.

[14]  S. Aiba,et al.  Phenotypic and functional characteristics of in vivo-activated Langerhans cells. , 1990, Journal of immunology.

[15]  M. Britschgi,et al.  Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells , 2001, British journal of pharmacology.

[16]  D. Schmitt,et al.  Fragrance and Contact Allergens in vitro Modulate the HLA–DR and E–Cadherin Expression on Human Epidermal Langerhans Cells , 1999, International Archives of Allergy and Immunology.

[17]  H. Jick,et al.  Assessment of adverse reactions within a drug surveillance program. , 1968, JAMA.

[18]  W. Pichler,et al.  Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ F T cell clones , 1998 .

[19]  W. Pichler,et al.  Recognition of local anesthetics by alphabeta+ T cells. , 1999, The Journal of investigative dermatology.

[20]  W. Pichler,et al.  Delayed Drug Hypersensitivity Reactions , 2003, Annals of Internal Medicine.

[21]  P. Devillier.  Comparing the new antihistamines: the role of pharmacological parameters , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  W. Pichler.  Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept , 2002, Current opinion in allergy and clinical immunology.

[23]  W. Pichler,et al.  Degeneracy and additional alloreactivity of drug-specific human αβ+ T cell clones , 2001 .

[24]  Lisa M. Ebert,et al.  A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells , 2004, The Journal of experimental medicine.

[25]  S. Nakagawa,et al.  p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. , 2003, The Journal of investigative dermatology.

[26]  J. Saloga,et al.  Detection of increased tyrosine phosphorylation in murine Langerhans cells after stimulation with contact sensitizers , 1999, Archives of Dermatological Research.

[27]  S. Valitutti,et al.  HLA-restricted , Processing-and Metabolism-independent Pathway of Drug Recognition by Human ab T Lymphocytes , 1998 .

[28]  M. Britschgi,et al.  Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. , 2006, Journal of the American Society of Nephrology : JASN.

[29]  S. Knowles,et al.  Idiosyncratic drug reactions: the reactive metabolite syndromes , 2000, The Lancet.

[30]  L. Kopelovich,et al.  Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.

[31]  W. Pichler,et al.  Transfection of Drug-Specific T-Cell Receptors into Hybridoma Cells: Tools to Monitor Drug Interaction with T-Cell Receptors and Evaluate Cross-Reactivity to Related Compounds , 2006, Molecular Pharmacology.

[32]  M. Pirmohamed,et al.  Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. , 2003, Molecular pharmacology.

[33]  M. Britschgi,et al.  Non‐covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen‐bound peptides , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  G. McCaughan,et al.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. , 2004, The Journal of clinical investigation.

[35]  P. Woster,et al.  A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. , 2000, The Journal of investigative dermatology.

[36]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[37]  J. Simon,et al.  Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short-term culture. , 1990, Journal of immunology.

[38]  M Pirmohamed,et al.  Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. , 1998, Chemical research in toxicology.

[39]  B. Sachs,et al.  Allergic and autoimmune reactions to xenobiotics: how do they arise? , 1998, Immunology today.

[40]  W. Pichler,et al.  Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. , 1997, The Journal of clinical investigation.

[41]  S. Valitutti,et al.  HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. , 1998, The Journal of clinical investigation.

[42]  W. Pichler,et al.  Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. , 2001, International immunology.

[43]  H. Merk,et al.  Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. , 2002, The Journal of allergy and clinical immunology.

[44]  M Pirmohamed,et al.  Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity. , 2000, Toxicology.

[45]  T. Bauer,et al.  Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy , 1997, European journal of immunology.

[46]  K. Frutig,et al.  T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. , 2000, The Journal of investigative dermatology.

[47]  M. Pirmohamed,et al.  Activation of T cells by carbamazepine and carbamazepine metabolites. , 2006, The Journal of allergy and clinical immunology.

[48]  W. Pichler,et al.  Distinct Serum Cytokine Levels in Drug– and Measles–Induced Exanthema , 1999, International Archives of Allergy and Immunology.

[49]  W. Pichler,et al.  Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions , 2006, The AAPS Journal.

[50]  V. Kindler,et al.  A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers , 2001, The Journal of Immunology.

[51]  Martine Bagot,et al.  Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. , 2002, The Journal of investigative dermatology.

[52]  H. Swanson.  Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. , 2004, Chemico-biological interactions.

[53]  I. N. Crispe,et al.  Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.

[54]  W. Pichler,et al.  Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones. , 1998, International immunology.

[55]  H. Merk,et al.  Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific αβ+ human T-cell clones , 2002 .

[56]  M. Mohamadzadeh,et al.  Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. , 1992, The Journal of investigative dermatology.

[57]  W. Pichler.  Immune mechanism of drug hypersensitivity. , 2004, Immunology and allergy clinics of North America.

[58]  M. Pirmohamed,et al.  Immunological Principles of Adverse Drug Reactions , 2000, Drug safety.

[59]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.